BioCryst Pharmaceuticals Inc. (BCRX) Fell -5.16% or -0.26 To Price $4.78 On Wednesday


BioCryst Pharmaceuticals Inc. (BCRX) fell -5.16% or -0.26 to $4.78. It is around 1.08 million shares traded, which is 110.57% compare to the average total volume 972742. The market cap of BCRX is $471.34 million. The year to date change is -7.35%. The 52 week price range is from $3.95 to $8.99. Price of BCRX have changed -4.36% during last week. It have changed 1.41% over last month, -0.98% over last 3 months, -3.82% over last 6 months and -41.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCRX is 5.07. It is 6.07% above current price. The 200-day Moving Averages for BCRX is 5.09. It is 6.49% above current price. The 52-week High is 8.99. It is 88.08% from the current price. The 52-week Low is 3.95. It is -17.36% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCRX is 10.97 on 2018-03-15. Short % to float is 11.68%. There are some statistics of BCRX. It is has market cap $471.34 million. The share outstanding is 98.61 million. The average volume is 972742. The revenue is 21.30M. It has 340.98M cash and 162.63M in debt. The gross profit is 19.72M. The percent of top 15 Institution holding is 76.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCRX is -154.16%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCRX is -49.07%.


Tags:

Share this post